Get started
Author

Jasper Trevelyan

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
2020 · Piotr Ponikowski, Bridget-Anne Kirwan, et al. · The Lancet · 795
PDF
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
2017 · Stuart J Connolly, John W Eikelboom, et al. · The Lancet · 754
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
2019 · Kausik K Ray, Helen M Colhoun, et al. · The Lancet Diabetes & Endocrinology · 315
PDF
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
2022 · Isla S Mackenzie, Christopher J Hawkey, et al. · The Lancet · 161
PDF
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
2022 · Sunil V. Rao, Bodo Kirsch, et al. · Circulation · 158
PDF
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
2021 · Gregory G. Schwartz, Gregory G. Schwartz, et al. · Journal of the American College of Cardiology · 148
PDF
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
2022 · Emil Hagström, P. Gabriel Steg, et al. · Circulation · 118
PDF
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
2023 · Divaka Perera, Matthew Ryan, et al. · JAMA Cardiology · 91
PDF
Impact of the recommendations for the redefinition of myocardial infarction on diagnosis and prognosis in an unselected United Kingdom cohort with suspected cardiac chest pain
2004 · Jasper Trevelyan, Edward W.A Needham, et al. · The American Journal of Cardiology · 55
Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene
2004 · Jasper Trevelyan, David J. Brull, et al. · The American Journal of Cardiology · 41
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
2021 · Gregory G. Schwartz, Michael Szarek, et al. · Diabetes Care · 40
PDF
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease
2024 · Florentina A. Simader, Christopher A. Rajkumar, et al. · Journal of the American College of Cardiology · 39
Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial
2023 · Divaka Perera, Holly P. Morgan, et al. · Circulation · 35
PDF
Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy
2024 · Saad M. Ezad, Margaret McEntegart, et al. · Journal of the American College of Cardiology · 33
Comparison of transthoracic echocardiography with harmonic imaging with transoesophageal echocardiography for the diagnosis of patent foramen ovale
2006 · J Trevelyan, R P Steeds · Postgraduate Medical Journal · 30
PDF
Lipoprotein lipase gene variants relate to presence and degree of microalbuminuria in Type II diabetes
2002 · R. Mattu, J. Trevelyan, et al. · Diabetologia · 30
PDF
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
2025 · P. Gabriel Steg, Michael Szarek, et al. · Circulation · 26
PDF
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
2024 · Shaun G Goodman, Philippe Gabriel Steg, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 25
PDF
Randomized Trial of Biolimus DCB for In-Stent Restenosis
2025 · Robert A. Byrne, Joo-Yong Hahn, et al. · JACC: Cardiovascular Interventions · 24
PDF
Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function
2005 · J Trevelyan, E W A Needham, et al. · Heart · 23
PDF
Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM)
2023 · Bryan P. Traynor, Sean Fitzgerald, et al. · Cardiovascular revascularization medicine · 18
Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction
2024 · Matthew Ryan, Dylan Taylor, et al. · JACC Heart Failure · 17
Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial
2026 · Christian Spaulding, Florian Krackhardt, et al. · Circulation · 16
Sources of diagnostic inaccuracy of conventional versus new diagnostic criteria for myocardial infarction in an unselected UK population with suspected cardiac chest pain, and investigation of independent prognostic variables
2003 · J Trevelyan, E W A Needham, et al. · Heart · 14
PDF
Multiple coronary aneurysms in a patient with neurofibromatosis type 1: case report and intravascular ultrasound of aneurysm
2001 · J Trevelyan, M Been, et al. · Postgraduate Medical Journal · 13
PDF
Works count: 51
Citation count: 3,052
H-index: 20
I10-index: 26
Year
Topic
Type